Soleno Therapeutics Inc SLNO 深 滬
已收盤 12-12 16:00:00 美东时间
52.00
+2.510
+5.07%
華盛通- 最 高52.79
- 今 開49.80
- 成交量 144.71万股
- 最 低 49.10
- 昨 收 49.49
- 總市值 27.43亿
- 52周最高 90.3199
- 市盈率 靜 --
- 換手率 2.74%
- 52周最低 41.50
- 委 比 11.05%
- 總股本 5274.69万
- 歷史最高 90.3199
- 量 比 0.95
- 振 幅 7.46%
- 歷史最低 1.81
- 每 手 1
- 風險率 14.22%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Rhythm Pharma Strikes Chord As Early PWS Trial Results Show Promise
Rhythm Pharma rises after early Prader-Willi trial data show reduced hunger and BMI, supporting plans for a Phase 3 study of setmelanotide.
12-12 02:17
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
Soleno Therapeutics announce the passing of Bill Harris, a valued Board member and Audit Committee Chairman since 2014. Harris, known for his integrity and expertise, had a prominent career in biopharmaceutical finance. Andrew Sinclair, a long-serving Board member, will assume the Audit Committee Chair position. Soleno focuses on rare disease therapeutics, with its FDA-approved VYKAT™ XR for Prader-Willi syndrome hyperphagia.
12-03 21:05
美股大行评级 | Stifel上调英伟达目标价升至250美元；大摩上调哔哩哔哩目标价升至27美元；NICE遭多家机构下调目标价
今日重点评级关注：Oppenheimer：维持Olema Pharmaceuticals"跑赢大市"评级，目标价从22美元升至45美元；Bernstein：维持Atlassian"跑赢大市"评级，目标价从290美元升至304美元
11-19 11:01
Wolfe Research Initiates Coverage On Soleno Therapeutics with Outperform Rating, Announces Price Target of $75
Wolfe Research analyst Kalpit Patel initiates coverage on Soleno Therapeutics (NASDAQ:SLNO) with a Outperform rating and announces Price Target of $75.
11-19 00:46
Soleno Therapeutics Unveils $100 Million Buyback Citing 'Underappreciated' Future
Soleno Therapeutics (SLNO) approved $100M share repurchase program & entered ASR agreement with Jefferies LLC to buy back its stock.
11-11 23:22
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers MSP Recovery (NASDAQ:MSPR) shares rose 93.0% to $0.61 during Tuesday's...
11-11 20:07
Soleno Therapeutics Announces $100M Accelerated Share Repurchase Plan
Soleno Therapeutics, Inc. ("Soleno") (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, announced today that its Board of Directors has authorized a share
11-11 20:01
美股大行评级 | 最高325美元！10家机构集体上调AMD目标价；Pinterest遭14家大行下调目标价；大行对优步目标价分歧大，5家下调5家上调
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从3美元升至9美元；HC Wainwright & Co.：上调CervoMed评级至"买入"，目标价从11美元升至25美元
11-06 09:55
Wells Fargo Maintains Overweight on Soleno Therapeutics, Lowers Price Target to $106
Wells Fargo analyst Derek Archila maintains Soleno Therapeutics (NASDAQ:SLNO) with a Overweight and lowers the price target from $123 to $106.
11-05 22:59
Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Shares of Teradata Corp (NYSE:TDC) rose sharply in pre-market trading after the...
11-05 18:09
